GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Amniotics AB (OSTO:AMNI) » Definitions » Accounts Receivable

Amniotics AB (OSTO:AMNI) Accounts Receivable : kr0.00 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Amniotics AB Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Amniotics AB's accounts receivables for the quarter that ended in Dec. 2023 was kr0.00 Mil.

Accounts receivable can be measured by Days Sales Outstanding.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Amniotics AB's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was kr-0.00.


Amniotics AB Accounts Receivable Historical Data

The historical data trend for Amniotics AB's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amniotics AB Accounts Receivable Chart

Amniotics AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Receivable
- - - 0.19 -

Amniotics AB Quarterly Data
Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.19 - - -

Amniotics AB Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Amniotics AB Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Amniotics AB's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Amniotics AB's accounts receivable are only considered to be worth 75% of book value:

Amniotics AB's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(8.212+0.75 * 0+0.5 * 0.534-10.547
-0-0)/2710.55
=-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Amniotics AB Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Amniotics AB's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Amniotics AB (OSTO:AMNI) Business Description

Traded in Other Exchanges
Address
Scheelevagen 2, Lund, SWE, 223 63
Amniotics AB is a biopharma company focusing on mesenchymal stem cells from amniotic fluid. It provides a novel platform for the production of medically superior mesenchymal stem cells including ethical and medically sound bio-banking opportunities for the newborn.

Amniotics AB (OSTO:AMNI) Headlines

From GuruFocus